Epidermal growth factor receptor antibody plus recombinant human endostatin in treatment of hepatic metastases after remnant gastric cancer resection

We report a 55-year-old male who developed advanced hepatic metastasis and peritoneal carcinomatosis after resection of remnant gastric cancer resection 3 mo ago. The patient only received epidermal growth factor （EGF） receptor antibody （Cetuximab） plus recombinant human endostatin （Endostar）. Anti-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2007-12, Vol.13 (45), p.6115-6118
Hauptverfasser:	Sun, Long, Ye, Huang-Yang, Zhang, Ying-Hong, Guan, Yong-Song, Wu, Hua
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - secondary Adenocarcinoma - surgery Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents - therapeutic use Cetuximab Endostatins - therapeutic use Fluorodeoxyglucose F18 Humans Liver Neoplasms - drug therapy Liver Neoplasms - secondary Male Middle Aged Positron-Emission Tomography Recombinant Proteins Stomach Neoplasms - pathology Stomach Neoplasms - surgery 肝转移重组体
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!